Delivery of chemotherapy after lobectomy for no-small cell lung cancertama: a comparison of complete video-assisted thoracoscopic surgery and thoracotomy

Guan-chao JIANG,Jun WANG,Xiao LI,Jun LIU,Jian-feng,Hui ZHAO,Yun LI,Fan YANG,Yan-guo LIU,Zu-li ZHOU,Liang BU
DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.2010.01.012
2010-01-01
Abstract:Objective To determine if thoraeoscopic (complete video-assisted thoracoscopic) lobectomy enables more effective administration of adjuvant chemotherapy than lobectomy through thoracotomy. Methods We reviewed the outcomes of 102 patients with non-small cell lung cancer (NSCLC) who underwent lobectomy and received adjuvant chemotherapy ( April 2005 to June 2009). The variables analyzed were time to initiation of chemotherapy, percentage of planned regimen received, number of delayed or reduced chemotherapy doses, toxicity grade, length of hospitalization, chest tube duration, 30-day mortality, and major postoperative complications( pneumonia, air leak, atrial fibrillation). Results Adjuvant chemotherapy was performed in 57 patients who underwent complete resection by thoracotomy and 45 patients by thoracoscopy. Patients undergoing thoraeoscopic lobectomy had significantly fewer reduced chemotherapy doses or changed approaches than conventional lobe ctomy (0 versus 10.5%, P = 0. 033 ). A higher percentage of patients undergoing thoracoscopie resection received 75% or more of planed adjuvant regimen ( 86.7% versus 70.2%, P = 0. 048 ), and a higher percentage of patients undergoing thora coseopic resection received all of four cycles planned adjuvant regimen without delayed or reduced doses (48.9% versus 29.8%, P = 0. 049). There were no significant differences in time to initiation of chemotherapy or toxicity. Conclusion Thoracoscopy was associated with an overall higher compliance rate in patients receiving adjuvant chemotherapy.
What problem does this paper attempt to address?